Variable Expression of Latent Membrane Protein in Nasopharyngeal Carcinoma Can Be Related to Methylation Status of the Epstein-Barr Virus BNLF-1 5'-flanking Region

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1991 Mar 1

PMID 1847471

Citations 28

Authors

L F Hu

J Minarovits

S L Cao

L Rymo

K Falk

G Klein

I Ernberg

Affiliations

Soon will be listed here.

Abstract

Seven virus-coded proteins, the nuclear proteins EBNA-1 to EBNA-6 and the latent membrane protein (LMP), are regularly expressed in Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines. In nasopharyngeal carcinoma (NPC), only EBNA-1 is regularly expressed; LMP is detected in about 65% of the tumors. In Burkitt's lymphoma tumors only EBNA-1 is expressed. We have recently shown that the methylation patterns of the EBV genome varied between these cell types. In virally transformed lymphoblastoid cell lines of normal origin, the EBV DNA is completely unmethylated. In contrast, in the Burkitt's lymphoma-derived cell line Rael and in a nude mouse-passaged NPC tumor, C15, there was an extensive methylation of CpG pairs. The methylation extended into the coding regions of the two expressed genes, EBNA-1 (in both tumor types) and LMP (in C15). Two presumptive control regions were exempted from this overall methylation: the oriP that contains both an origin of DNA replication and an EBNA-1-dependent enhancer and the 5'-flanking region of the BNLF-1 open reading frame that codes for LMP. The latter was only exempted in the LMP expressing NPC. We have now investigated the relation between expression of LMP and methylation of DNA in the 5'-flanking 1 kb region of BNLF-1, coding for LMP. LMP was methylated in 3 of 12 NPC biopsies that did not express LMP but was partially or totally unmethylated in the remaining 9 that expressed the protein. The three BNLF-1 exons were highly methylated in all the tumors. The oriP region was unmethylated in all the tumors, as in the previously studied Rael cell line and nude mouse-passaged NPC. Also, the BamHI W enhancer region involved in the expression of EBNA nuclear proteins was methylated. None of the biopsies expressed EBNA-2. Our data show that the EBV genomes are highly methylated in NPC tumors. The strong reverse correlation between the methylation of the putative control region of the LMP gene and the expression of LMP suggests that methylation has a role in the regulation of this gene.

Citing Articles

Targeting the crosstalk of epigenetic modifications and immune evasion in nasopharyngeal cancer.

Looi C, Foong L, Chung F, Khoo A, Loo E, Leong C Cell Biol Toxicol. 2023; 39(6):2501-2526.

PMID: 37755585 DOI: 10.1007/s10565-023-09830-9.

MC180295 Inhibited Epstein-Barr Virus-Associated Gastric Carcinoma Cell Growth by Suppressing DNA Repair and the Cell Cycle.

Fujii T, Nishikawa J, Fukuda S, Kubota N, Nojima J, Fujisawa K Int J Mol Sci. 2022; 23(18).

PMID: 36142506 PMC: 9500863. DOI: 10.3390/ijms231810597.

The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer.

Nishikawa J, Iizasa H, Yoshiyama H, Nakamura M, Saito M, Sasaki S Int J Mol Sci. 2017; 18(8).

PMID: 28757548 PMC: 5577998. DOI: 10.3390/ijms18081606.

The Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A/TGFβ and β1 integrin signalling.

Morris M, Dawson C, Laverick L, Davis A, Dudman J, Raveenthiraraj S Sci Rep. 2016; 6:19533.

PMID: 26782058 PMC: 4726061. DOI: 10.1038/srep19533.

Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay.

Nawaz I, Moumad K, Martorelli D, Ennaji M, Zhou X, Zhang Z Clin Epigenetics. 2015; 7:89.

PMID: 26300994 PMC: 4546349. DOI: 10.1186/s13148-015-0119-8.

References

Becker P, Ruppert S, Schutz G . Genomic footprinting reveals cell type-specific DNA binding of ubiquitous factors. Cell. 1987; 51(3):435-43. DOI: 10.1016/0092-8674(87)90639-8. View

Kovesdi I, Reichel R, Nevins J . Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. Proc Natl Acad Sci U S A. 1987; 84(8):2180-4. PMC: 304612. DOI: 10.1073/pnas.84.8.2180. View

Watt F, Molloy P . Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev. 1988; 2(9):1136-43. DOI: 10.1101/gad.2.9.1136. View

Hennessy K, Fennewald S, Hummel M, Cole T, Kieff E . A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc Natl Acad Sci U S A. 1984; 81(22):7207-11. PMC: 392107. DOI: 10.1073/pnas.81.22.7207. View

Kelley D, Pollok B, Atchison M, PERRY R . The coupling between enhancer activity and hypomethylation of kappa immunoglobulin genes is developmentally regulated. Mol Cell Biol. 1988; 8(2):930-7. PMC: 363225. DOI: 10.1128/mcb.8.2.930-937.1988. View

Hitt M, Allday M, Hara T, Karran L, Jones M, Busson P . EBV gene expression in an NPC-related tumour. EMBO J. 1989; 8(9):2639-51. PMC: 401270. DOI: 10.1002/j.1460-2075.1989.tb08404.x. View

Bonnerot C, Daeron M, Varin N, Amigorena S, Hogarth P, Even J . Methylation in the 5' region of the murine beta Fc gamma R gene regulates the expression of Fc gamma receptor II. J Immunol. 1988; 141(3):1026-33. View

Baichwal V, Sugden B . The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation. Oncogene. 1989; 4(1):67-74. View

Dynan W . Understanding the molecular mechanism by which methylation influences gene expression. Trends Genet. 1989; 5(2):35-6. DOI: 10.1016/0168-9525(89)90016-4. View

10.

Keshet I, Yisraeli J, Cedar H . Effect of regional DNA methylation on gene expression. Proc Natl Acad Sci U S A. 1985; 82(9):2560-4. PMC: 397603. DOI: 10.1073/pnas.82.9.2560. View

11.

Ghosh D, Kieff E . cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site. J Virol. 1990; 64(4):1855-8. PMC: 249329. DOI: 10.1128/JVI.64.4.1855-1858.1990. View

12.

Fahraeus R, Rymo L, Rhim J, Klein G . Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature. 1990; 345(6274):447-9. DOI: 10.1038/345447a0. View

13.

Dawson C, Rickinson A, Young L . Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature. 1990; 344(6268):777-80. DOI: 10.1038/344777a0. View

14.

DOERFLER W . DNA methylation and gene activity. Annu Rev Biochem. 1983; 52:93-124. DOI: 10.1146/annurev.bi.52.070183.000521. View

15.

Feinberg A, Vogelstein B . A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983; 132(1):6-13. DOI: 10.1016/0003-2697(83)90418-9. View

16.

Klein G, Dombos L, Gothoskar B . Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Int J Cancer. 1972; 10(1):44-57. DOI: 10.1002/ijc.2910100108. View

17.

Fahraeus R, Jansson A, Ricksten A, Sjoblom A, Rymo L . Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proc Natl Acad Sci U S A. 1990; 87(19):7390-4. PMC: 54752. DOI: 10.1073/pnas.87.19.7390. View

18.

Saluz H, Feavers I, Jiricny J, Jost J . Genomic sequencing and in vivo footprinting of an expression-specific DNase I-hypersensitive site of avian vitellogenin II promoter reveal a demethylation of a mCpG and a change in specific interactions of proteins with DNA. Proc Natl Acad Sci U S A. 1988; 85(18):6697-700. PMC: 282044. DOI: 10.1073/pnas.85.18.6697. View

19.

Woisetschlaeger M, Strominger J, Speck S . Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes. Proc Natl Acad Sci U S A. 1989; 86(17):6498-502. PMC: 297871. DOI: 10.1073/pnas.86.17.6498. View

20.

Rowe M, EVANS H, Young L, Hennessy K, Kieff E, Rickinson A . Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J Gen Virol. 1987; 68 ( Pt 6):1575-86. DOI: 10.1099/0022-1317-68-6-1575. View